BIOQUELL SHORTLISTED FOR UK STOCK MARKET AWARD
Bioquell UK Ltd (www.bioquell.com; tel: +44 (0) 1264 835835) – one of the leading global experts in reducing the risk of bio-contamination in the life science, healthcare and pharmaceutical markets – has been shortlisted in the highly competitive Best Health Care & Pharmaceutical PLC category of the prestigious UK Stock Market awards.
The UK Stock Market awards (www.stockmarketawards.com), now in their 8th year, are firmly established as one of the leading award ceremonies for UK publicly listed companies, the individuals behind them and the advisers who ably assist them. The awards are unique as they offer the private investment community the chance to have their say on who they believe to have created true shareholder value.
The shortlist has been compiled by senior individuals from the world of corporate finance, law, financial services, accounting, public relations and media. Each person has experience with companies on the stock market, either as an investor, adviser, analyst or journalist.
The factors each person will have considered when putting forward their choices include;
The next step in the awards process is for a 4 week public vote to take place. The voting commenced on April 26th 2018 and will finish on May 25th 2018.
The voters are HNW investors, predominantly customers of AJ Bell* and Shares magazine.
Once voting comes to an end all votes will be counted and the companies and individuals that received the most votes during the voting period will be the ones announced as the respective category winners at the black-tie gala awards ceremony on Monday 25th June 2018.
The awards ceremony will take place at the Sheraton Grand London Park Lane Hotel in London.
Vote for Bioquell by simply clicking on the link below and select Bioquell from the ‘Healthcare & Pharmaceutical’ list. http://www.stockmarketawards.com/vote/
Bioquell is a well-established global leader in the design and manufacture of bio-decontamination solutions for risk reduction within the pharmaceutical, life science and healthcare sectors. The UK-based company operates worldwide through its own sales offices and international distributor network.
Bioquell’s industry-leading Hydrogen Peroxide Vapor technology is used across the world to eradicate biological contaminants including problematic bacteria, viruses and fungi on every exposed surface in any suitable enclosure to ensure maximum uptime. Deployment of Bioquell’s Hydrogen Peroxide Vapor process provides residue-free, safe and repeatable disinfection of rooms, buildings, equipment and sensitive electronics. It is a clear alternative when replacing traditional methods such as formaldehyde or chlorine-based products.
For product information please contact Jason Merrill, Bioquell, tel: +1 215 682 0225 or email: firstname.lastname@example.org
For press information please contact Anita Miault, Bioquell, tel: +441264835836 or email: email@example.com
View and Download the PDF of this Release Here: